REGISTERED
on 30 Aug 2022
Last Applicant/ Owned by
Tokyo 107-0052
JP
Serial Number
79288175 filed on 09th Apr 2020
Registration Number
6829584 registered on 30th Aug 2022
Correspondent Address
Rebecca Liebowitz
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
SOSEI HEPTARES
Bio-technology, pharmaceutical and scientific testing, research and development; biological research services; research and development services in the pharmaceutical and biopharmaceutical fields;, research and development services in the pharmaceutical and biopharmaceutical fields, namely, in the field of technologies related to proteins and G-protein-coupled receptors; research services in biolo Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Bio-technology, pharmaceutical and scientific testing, research and development; biological research services; research and development services in the pharmaceutical and biopharmaceutical fields;, research and development services in the pharmaceutical and biopharmaceutical fields, namely, in the field of technologies related to proteins and G-protein-coupled receptors; research services in biology and chemistry fields; pharmaceutical research services in chemical and biological drug discovery and development; scientific and pharmaceutical research and development services for identifying lead chemical compounds; scientific analysis and research services in medicinal and synthetic chemistry; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; pharmaceutical research and development in the nature of research, creation, development and provision of chemical and biological drug targets for non-medical scientific screening purposes; technical diagnostic testing services, namely, scientific and pharmaceutical research and development; scientific research, analysis and examination for identification of compounds through automated screening processes, being scientific and pharmaceutical research and development; research and development services in chemical and biological pharmaceutical development; provision of information, advisory services and consultancy relating to the aforesaid services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Biological products for medical use in chemical and biological drug discovery, lead identification and diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological products for therapeutic purposes, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; proteins for medical use in chemical and biological drug discovery, lead identification and diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; medicines, namely, diagnostic preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; cleaning agent for medical use, namely, medical cleansers for skin wounds; biological formulation for medical use in developing chemical and biological pharmaceutical products, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological formulation for medical use in identifying lead chemical and biological products, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological formulation for medical diagnostic use, namely, diagnostic preparations for medical use; biological formulation for therapeutic use, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; proteins and G-protein-coupled receptors for medical use in drug discovery; biologicals and small chemical entities, including proteins, G-protein-coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for therapeutic purposes, namely, diagnostic preparations for medical use; proteins, G-protein-coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for use in medical diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; medical oiled paper; drug delivery agents in the form of edible pharmaceutical wafers for wrapping powdered pharmaceuticals; gauze for dressings; specialized capsules for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; eye patches for medical purposes, ear bandages; menstrual bands being sanitary pads; menstrual tampons; menstrual napkins, namely, menstrual symptom treatment preparations; menstrual underwear, namely, panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; collodion for pharmaceutical purposes; cotton swabs for medical purposes; breast-nursing pads
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
chemical products and proteins for manufacturing chemical and biological pharmaceutical products; chemical products and proteins for the scientific research of chemical and biological pharmaceutical products; chemical products and proteins for diagnostic use, except medical or veterinary uses, namely, diagnostic preparations for scientific use; proteins and specifically proteins in the nature of G-protein-coupled receptors for manufacturing pharmaceutical products; proteins and specifically proteins in the nature of G-protein-coupled receptors, for the scientific research of pharmaceutical products; chemicals and proteins for chemical and biological drug discovery, lead identification and diagnostics, namely, chemical and biological preparations for use in scientific purposes; proteins and G-protein-coupled receptors for drug discovery purpose, namely, proteins and biological preparations for use in scientific research; chemicals preparations and biologicals preparations for scientific research purposes, being proteins, transmembrane proteins and G proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for chemical and biological drug discovery, lead identification and diagnostics; proteins, including transmembrane proteins and G-proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, all for use in scientific pharmaceutical research and scientific pharmaceutical research in the nature of drug discovery purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79288175
Mark Type
No Service Mark
Attorney Docket Number
No 60895-533018
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 14th Jun 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 27th Dec 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 07th Dec 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| 07th Dec 2022 | FINAL DISPOSITION PROCESSED |
| 30th Nov 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 04th Nov 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| 30th Aug 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 30th Aug 2022 | REGISTERED-PRINCIPAL REGISTER |
| 05th Jul 2022 | NOTIFICATION PROCESSED BY IB |
| 14th Jun 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |